RTEMSY
Live / Registered — Registered (as of 21 Apr 2026)
What this means for you
Registered since 21 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Apr 2032: the §71 affidavit of use).
Record
- Serial number
- 79426153
- Registration number
- 8217534
- Mark type
- Word mark
- Filed
- 24 Apr 2025
- Published for opposition
- 03 Mar 2026
- Registered
- 21 Apr 2026
- Next maintenance filing
- §71 affidavit of use, due by 21 Apr 2032 (grace period to 21 Oct 2032)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; immunomodulators; immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology.
Owner
Prosecution history
- 21 May 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTICE OF PUBLICATION
- 06 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2026 — ASSIGNED TO EXAMINER
- 28 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jun 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 19 Jun 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB